FDA Announces First Participant Selected for TEMPO for Digital Health Devices Pilot

The U.S. Food and Drug Administration today announced the first manufacturer selected for the Technology-Enabled Meaningful Patient Outcomes (TEMPO) for Digital Health Devices Pilot.